Please assess the completion status of the following clinical trial:

Trial Title: Early Assessment of Anthracycline-induced Cardiotoxicity (CARDIOTOX)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Histologically proven lymphoma (Hodgkin's or non-Hodgkin's)~* Age \> 18 y/o and \< 70 y/o~* WHO score \< or = 2~* Life expectancy \> 6 mo~* Left ventricular ejection fraction \> 50%~* Informed consent~Exclusion Criteria:~* Previous chemotherapy using anthracyclines~* History of radiation therapy~* History of congestive heart failure~* History of chronic renal insufficiency~* Contra indication to MR examination~* Atrial fibrillation and significant arrhythmia~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).